HCC
Clinical trials for HCC explained in plain language.
Never miss a new study
Get alerted when new HCC trials appear
Sign up with your email to follow new studies for HCC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New Four-Drug combo aims to tackle tough liver cancer cases
Disease control Not yet recruitingThis study is testing a new combination treatment for people with advanced liver cancer (hepatocellular carcinoma) who also have high blood pressure in their liver (portal hypertension) due to cirrhosis. The treatment combines a minimally invasive procedure (TACE) with three drug…
Matched conditions: HCC
Phase: PHASE2 • Sponsor: Tongji Hospital • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
New combo attack on liver cancer aims to stop it from returning
Disease control Not yet recruitingThis study is testing if a new treatment approach can better control liver cancer. It will compare two groups: one receives a drug (sintilimab) and targeted radiation before surgery, while the other has surgery right away. The main goal is to see if the pre-surgery treatment lowe…
Matched conditions: HCC
Phase: PHASE2 • Sponsor: Lei ZHAO • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
New hope for tough liver cancers: study tests two powerful drug combos
Disease control Not yet recruitingThis study aims to find the best combination treatment for advanced liver cancer that cannot be removed by surgery. It will compare two different local drug delivery methods (TACE and HAIC), each combined with two other cancer drugs, in about 364 patients. The main goal is to see…
Matched conditions: HCC
Sponsor: Tongji Hospital • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
AI vs. liver cancer: can computers pick who needs treatment?
Disease control Not yet recruitingThis study aims to see if an artificial intelligence (AI) model can better identify which liver cancer patients need immunotherapy after surgery to prevent the cancer from coming back. It will follow 300 patients who have had their liver tumors surgically removed. The AI will ana…
Matched conditions: HCC
Sponsor: Tongji Hospital • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC
-
New combo attack on tough liver tumors
Disease control Not yet recruitingThis study is testing if combining two standard treatments works better for advanced liver cancer that cannot be removed by surgery. It will give 90 patients both a drug that boosts the immune system and a procedure that directly targets the tumor in the liver. The goal is to see…
Matched conditions: HCC
Phase: PHASE2 • Sponsor: Chang Gung Memorial Hospital • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC
-
New scan aims to pinpoint liver cancer
Diagnosis Not yet recruitingThis study is testing a new type of medical scan to see if it can better detect and locate liver cancer tumors. It will involve 6 people who have or are strongly suspected to have liver cancer. The main goal is to see how a special imaging agent moves through the body, if it's sa…
Matched conditions: HCC
Phase: NA • Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Diagnosis
Last updated Mar 17, 2026 12:55 UTC
-
New blood test could predict liver Cancer's return after surgery
Diagnosis Not yet recruitingThis study is testing a new blood test that detects tiny amounts of leftover cancer cells after liver cancer surgery. Researchers want to see if this test can better predict which patients' cancer will return and identify who might benefit from additional immunotherapy treatment.…
Matched conditions: HCC
Phase: NA • Sponsor: Tongji Hospital • Aim: Diagnosis
Last updated Mar 09, 2026 14:22 UTC